Intragraft expression of transforming growth factor β1 gene in isolated glomeruli from human renal transplants

British Journal of Surgery

Volumn 86, Issue 9, 1999, Pages 1144-1148

  Nicholson, M L ^a   Bicknell, G R ^a   Barker, G ^a   Doughman, T M ^a   Williams, S T ^a   Furness, P N ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; COMPLEMENTARY DNA; CYCLOSPORIN A; CYTOKINE; MATRIX PROTEIN; MESSENGER RNA; PREDNISOLONE; STEROID; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGRAFT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE EXPRESSION; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY, NEEDLE; COLLAGEN; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0032888571     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01202.x     Document Type: Article

References (25)

1. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 1991; 52: 389-98.
2. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491-9.
3. Lemstrom K, Koskinen P, Hayry P. Molecular mechanisms of chronic renal allograft rejection. Kidney Int Suppl 1995; 52: S2-10.
4. Kasiske BL, Kalil RSN, Lee HS, Rao KV. Histopathologic findings associated with a chronic, progressive decline in renal allograft function. Kidney Int 1991; 40: 514-24.
5. Furness PN. Extracellular matrix and the kidney. J Clin Pathol 1996; 49: 355-259.
6. el Nahas AM. Pathways to renal fibrosis. Exp Nephrol 1995; 3: 71-5.
7. Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 1993; 34(Part B): 43-67.
8. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-601.
9. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-4.
10. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4.
11. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-27.
12. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154-63.
13. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-88.
14. Nicholson ML, Attard AR, Bell A, Donnelly PK, Veitch PS, Bell PRF. Renal transplant biopsy using real time ultrasound guidance. Br J Urol 1990; 65: 564-5.
15. Bicknell GR, Shaw JA, Pringle JH, Furness PN. Amplification of specific mRNA from a single human glomerulus with an approach to the separation of epithelial cell mRNA. J Pathol 1996; 180: 188-93.
16. Hall LL, Bicknell GR, Primrose L, Pringle JH, Shaw JA, Furness PN. Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. Biotechniques 1998; 24: 652-8.
17. Nicholson ML, Bailey E, Williams ST, Harris KPG, Furness PN. Computerised histomorphometric assessment of protocol renal transplant biopsies for surrogate markers of chronic rejection. Transplantation; (in press).
18. Furness PN. The use of digital images in pathology. J Pathol 1997; 183: 253-63.
19. Yamamoto T, Noble NA, Cohen H, Nast CC, Hishida A, Gold LT et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-9.
20. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J et al. Intragraft TGF-beta 1 mRNA. a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996; 49: 1297-303.
21. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23: 647-55.
22. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162-9.
23. Fine LG, Norman JT, Ong A. Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int Suppl 1995; 49: S48-50.
24. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int 1991; 39: 550-6.
25. Wallace WA, Howie SE, Lamb D, Salter DM. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J Pathol 1995; 175: 415-20.